Duopharma Biotech Bhd (XKLS:7148) LT-Debt-to-Total-Asset : 0.34 (As of Dec. 2024)

View and export this data going back to 2002. Start your Free Trial

What is Duopharma Biotech Bhd LT-Debt-to-Total-Asset?

LT Debt to Total Assets is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. It is calculated as a company's Long-Term Debt & Capital Lease Obligationdivide by its Total Assets. Duopharma Biotech Bhd's long-term debt to total assests ratio for the quarter that ended in Dec. 2024 was 0.34.

Duopharma Biotech Bhd's long-term debt to total assets ratio declined from Dec. 2023 (0.36) to Dec. 2024 (0.34). It may suggest that Duopharma Biotech Bhd is progressively becoming less dependent on debt to grow their business.

Duopharma Biotech Bhd LT-Debt-to-Total-Asset Historical Data

The historical data trend for Duopharma Biotech Bhd's LT-Debt-to-Total-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Duopharma Biotech Bhd LT-Debt-to-Total-Asset Chart

Duopharma Biotech Bhd Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

LT-Debt-to-Total-Asset

Get a 7-Day Free Trial

0.24

0.26

0.24

0.36

0.34

Duopharma Biotech Bhd Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
LT-Debt-to-Total-Asset	Get a 7-Day Free Trial															0.36	0.36	0.35	0.35	0.34

Duopharma Biotech Bhd LT-Debt-to-Total-Asset Calculation

Duopharma Biotech Bhd's Long-Term Debt to Total Asset Ratio for the fiscal year that ended in Dec. 2024 is calculated as

LT Debt to Total Assets (A: Dec. 2024 )	=	Long-Term Debt & Capital Lease Obligation (A: Dec. 2024 )	/	Total Assets (A: Dec. 2024 )
	=	464.523	/	1376.998
	=	0.34

Duopharma Biotech Bhd's Long-Term Debt to Total Asset Ratio for the quarter that ended in Dec. 2024 is calculated as

LT Debt to Total Assets (Q: Dec. 2024 )	=	Long-Term Debt & Capital Lease Obligation (Q: Dec. 2024 )	/	Total Assets (Q: Dec. 2024 )
	=	464.523	/	1376.998
	=	0.34

Duopharma Biotech Bhd (XKLS:7148) LT-Debt-to-Total-Asset Explanation

LT Debt to Total Asset is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. A year-over-year decrease in this metric would suggest the company is progressively becoming less dependent on debt to grow their business.

Duopharma Biotech Bhd LT-Debt-to-Total-Asset Related Terms

Thank you for viewing the detailed overview of Duopharma Biotech Bhd's LT-Debt-to-Total-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

Duopharma Biotech Bhd Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Duopharma Biotech Bhd (XKLS:7148) » Definitions » LT-Debt-to-Total-Asset

Comparable Companies

Traded in Other Exchanges

N/A

Address

Lot 2599, Jalan Seruling 59, Kawasan 3, Taman Klang Jaya, Klang, SGR, MYS, 41200

Website

https://www.duopharmabiotech.com

Duopharma Biotech Bhd is an investment holding company engaged in manufacturing pharmaceuticals. It develops, manufactures, and markets generic and over-the-counter pharmaceutical products. The operating segment of the company is the manufacturing and distribution of pharmaceutical products. The principal activities of its subsidiary are to carry out business as a manufacturer, distributor, importer, and exporter of pharmaceutical products and medicines.

Duopharma Biotech Bhd Headlines

No Headlines